Home›Companies›Healthcare›Synkopi Medical

Synkopi, Inc.

Develops a heart pressure monitor for physicians and their patients.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 16, 2026·Suggest an edit

About Synkopi Medical

Synkopi Medical is a private company based in Palo Alto, California, incorporated in 2022 in Delaware. It has reported $372,000 raised in one offering on Form D since September 2026. Its chief executive is Suresh Gurunathan.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 27, 2026Sep 16, 2026$372,000of $1.5M target3$124KSimple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Synkopi Medical's Form D filed Sep 16, 2026.

Alan Ostroff
Alan Ostroff
Co-founder and director
Frank Fischer
Frank Fischer
Chairman of the Board
Suresh Gurunathan
Suresh Gurunathan
Co-founder and CEO, director

Sources

  1. SECSynkopi, Inc. filing history